H-Arg(NH2)-OH · flavianate

H-Arg(NH2)-OH · flavianate is an arginine amino acid derivative presented as a flavianate salt, featuring the L-arginine backbone with a free α-amino group and α-carboxylic acid functionality alongside the side-chain guanidinium group. The guanidinium moiety provides strong basicity and multidentate hydrogen-bonding capacity, which strongly influences solubility, salt formation, and coupling behavior in peptide chemistry. Salt pairing with flavianic acid modulates the ionic environment around the cationic arginine side chain, supporting handling as a crystalline or isolable intermediate while preserving the stereochemical integrity of the chiral center at the α-carbon. The combination of an amino acid core and a protected/controlled ionic form makes the compound suitable as a chiral building block for downstream amino acid derivatization and for incorporation into peptide and peptidomimetic scaffolds.

1. Protected Amino Acids

H-Arg(NH2)-OH · flavianate is used in protected amino acid synthesis planning where the free α-amino and α-carboxyl groups can be selectively transformed into coupling-ready derivatives. The side-chain guanidinium group can be retained in a controlled ionic state during salt formation, then converted to a protected guanidine form or orthogonally managed guanidinium chemistry depending on the intended peptide strategy. Salt-controlled handling can support reproducible metering and intermediate preparation prior to conversion into N-protected or C-activated arginine building blocks. Downstream, the resulting protected arginine derivatives enable stepwise peptide coupling with stereochemical fidelity at the α-carbon.

2. Peptide Synthesis

H-Arg(NH2)-OH · flavianate serves as an arginine source for peptide building block preparation in solid-phase or solution-phase peptide synthesis workflows. The α-amino acid functionality supports formation of peptide bonds at the α-position, while the guanidinium side chain participates in hydrogen bonding patterns that are often important for peptide structure and receptor-like recognition. Flavianate salt form can be used as a practical intermediate that maintains the cationic side-chain environment during early-stage derivatization steps, including conversion to activated esters, acid chlorides, or coupling partners compatible with standard peptide coupling reagents. Resulting arginine-containing peptides and arginine-rich sequences can be generated for chemical biology studies, SAR investigations, and peptidomimetic construction where guanidinium-driven interactions are central.

3. Chemical Biology Conjugation

H-Arg(NH2)-OH · flavianate is applicable to chemical biology research requiring guanidinium-bearing handles for biomolecule modification and molecular recognition studies. The free amino acid core can be transformed into amide-forming or activated carboxyl intermediates, while the guanidinium group can drive electrostatic and hydrogen-bonding interactions that influence conjugate binding to nucleic acids, proteins, or model membranes. Flavianate salt pairing can assist in isolating the arginine-derived intermediate prior to conversion into conjugation-ready derivatives such as side-chain functionalized arginine analogs or linker-bearing arginine fragments. Downstream use includes preparation of arginine-containing probes, affinity reagents, and label-bearing constructs for studying biomolecular interactions in complex chemical environments.

4. SAR Studies

H-Arg(NH2)-OH · flavianate can be employed in structure-activity relationship studies through controlled incorporation of arginine residues into peptide and peptidomimetic series. The chiral α-carbon stereochemistry and the guanidinium side chain provide a well-defined stereoelectronic motif that can be systematically varied by changing protection/derivatization state, linker length, or N-/C-terminal modification. Salt form influences ion pairing and can be leveraged during intermediate preparation to maintain consistent handling of the cationic side chain before final assembly into analog libraries. Generated arginine-containing analogs support comparative evaluation of binding and functional readouts where side-chain charge distribution and hydrogen-bonding geometry are key determinants.

5. Pharmaceutical Intermediate Preparation

H-Arg(NH2)-OH · flavianate is suitable for pharmaceutical intermediate preparation where arginine-derived fragments are required for synthesis of peptides, peptidomimetics, and other nitrogen-rich scaffolds. The amino acid core enables conversion into N-protected and/or C-activated intermediates that can be routed into drug-like candidate synthesis while maintaining the stereochemical configuration of the α-center. Guanidinium functionality can be protected or transformed into controlled guanidine derivatives to manage reactivity during multi-step sequences, including late-stage peptide coupling and fragment assembly. Downstream, the compound supports industrial fine chemical synthesis routes that require chiral amino acid intermediates with defined ionic character and reliable conversion to coupling-ready building blocks.

6. Process Chemistry Intermediate

H-Arg(NH2)-OH · flavianate is relevant to process chemistry as an isolable arginine-based starting material whose salt form can improve handling, storage stability, and reproducibility in intermediate preparation. The presence of both α-amino and α-carboxyl groups allows conversion into standardized coupling partners, while the guanidinium side chain can be managed through protection-group selection to align with the chosen manufacturing sequence. Flavianate salt pairing can influence dissolution behavior and downstream filtration or crystallization steps when producing protected arginine derivatives at scale. Resulting arginine intermediates can then feed into peptide building block manufacturing, industrial peptide synthesis supply chains, and specialty chemical production requiring consistent chiral amino acid inputs.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis